心率变异性生物反馈可穿戴设备和远程压力管理教练减轻焦虑症状的初步研究。
Pilot Study on Reducing Symptoms of Anxiety with a Heart Rate Variability Biofeedback Wearable and Remote Stress Management Coach.
机构信息
Lief Therapeutics, 2703 Seventh Street #301, Mailbox #123, Berkeley, CA, 94710, USA.
Alliant International University, San Diego, USA.
出版信息
Appl Psychophysiol Biofeedback. 2021 Dec;46(4):347-358. doi: 10.1007/s10484-021-09519-x.
We assessed the feasibility of using a consumer friendly, heart rate variability biofeedback (HRVB) wearable device in conjunction with a remote stress management coach to reduce symptoms of anxiety. We utilized a discreet, continuously wearable electrocardiogram device, the Lief Smart Patch, which measures and records heart rate and HRV in real time, and guides HRVB exercises using vibrations and visual cues. During the 8-week study, participants (N = 14) wore the Lief Smart Patch, participated in HRVB with the device, utilized the mobile app, and communicated with a remote stress management coach. We collected self-report survey responses to measure symptoms of anxiety (GAD-2) and depression (PHQ-2) every 2 weeks, as well as HRV data throughout the study. Participants' mean GAD-2 score began at 4.6 out of 6. By the trial's completion, the group's mean GAD-2 score dropped to 1.7 (t = 11.0, p < .001) with only 2 of the 14 subjects remaining over the clinical threshold of high anxiety. Similarly, the group's mean PHQ-2 score dropped from 2.93 to 1.29 (t = 3.54, p < .01). In addition, participants increased their HRV (RMSSD) by an average of + 11.4 ms after participating in a low dose biofeedback exercise. These findings suggest that engaging in HRVB through a discreet wearable device in conjunction with a remote stress management program may be effective for reducing symptoms of anxiety and depression.
我们评估了使用消费者友好型心率变异性生物反馈(HRVB)可穿戴设备结合远程压力管理教练来减轻焦虑症状的可行性。我们使用了一款 discreet 的、连续可穿戴的心电图设备——Lief Smart Patch,它可以实时测量和记录心率和 HRV,并通过振动和视觉提示引导 HRVB 练习。在 8 周的研究中,参与者(N=14)佩戴 Lief Smart Patch,使用设备进行 HRVB,使用移动应用程序,并与远程压力管理教练进行沟通。我们每两周收集一次自我报告调查结果,以测量焦虑症状(GAD-2)和抑郁症状(PHQ-2),并在整个研究过程中收集 HRV 数据。参与者的平均 GAD-2 评分从 6 分中的 4.6 分开始。到试验结束时,该组的平均 GAD-2 评分降至 1.7(t=11.0,p<.001),14 名受试者中只有 2 名仍高于高焦虑的临床阈值。同样,该组的平均 PHQ-2 评分从 2.93 降至 1.29(t=3.54,p<.01)。此外,参与者在进行低剂量生物反馈练习后,HRV(RMSSD)平均增加了+11.4ms。这些发现表明,通过 discreet 的可穿戴设备结合远程压力管理计划进行 HRVB 可能是减轻焦虑和抑郁症状的有效方法。